Evidence map›Paper›PMID 31321423›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2020

A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.

Ellen Meier, Bruce R Lindgren, Amanda Anderson, Sarah A Reisinger, Kaila J Norton, Joni Jensen, Lori Strayer, Laura Dick, Mei-Kuen Tang, Menglan Chen and 8 more

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ellen MeierDepartment of Psychology, University of Wisconsin-Stevens Point, WI.
Bruce R LindgrenMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Amanda AndersonDepartment of Psychiatry, University of Minnesota, Minneapolis, MN.
Sarah A ReisingerCollege of Medicine, Ohio State University, Columbus, OH.
Kaila J NortonRoswell Park Comprehensive Cancer Center, Buffalo, NY.
Joni JensenDepartment of Psychiatry, University of Minnesota, Minneapolis, MN.
Lori StrayerDepartment of Psychiatry, University of Minnesota, Minneapolis, MN.
Laura DickDepartment of Psychiatry, University of Minnesota, Minneapolis, MN.
Mei-Kuen TangMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Menglan ChenMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Steven G CarmellaMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Stephen S HechtMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Sharon E MurphyMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Jing YangMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Irina StepanovMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.
Richard J O'ConnorRoswell Park Comprehensive Cancer Center, Buffalo, NY.
Peter G ShieldsCollege of Medicine, Ohio State University, Columbus, OH.
Dorothy K HatsukamiMasonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Tobacco Constituent and Biomarker Assessment CoreU19CA157345 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K, SHIELDS, PETER G. · 2012 to 2016
$13.3M
Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
Nornicotine in smokeless tobacco as a precursor for carcinogen exposureR01CA180880 · NCI · UNIVERSITY OF MINNESOTA · PI STEPANOV, IRINA · 2014 to 2018
$2.4M
NCATS NIH HHS UL1 TR000062NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA180880NCI NIH HHS U19 CA157345NIDA NIH HHS T32 DA007097
6 · The paper itself

Abstract

introductionThis 8-week multisite, randomized controlled trial of snus examined the differential effects of instructions on (1) snus use, (2) smoking and smoking-related measures, and (3) exposure to tobacco-related constituents.

methodUS adult daily cigarette smokers (n = 150; 43.3% female; Medianage = 43.5) were recruited from Minneapolis, Minnesota; Columbus and Coshocton, Ohio; and Buffalo, New York. Following a 1-week sampling phase of snus, participants who used at least 7 pouches were randomized to either (1) partial substitution (PS; "use snus as you like with your cigarettes"), (2) complete substitution (CS; "avoid cigarettes"), or (3) usual brand cigarettes (UB). Analyses included between-group analyses (eg, PS vs. CS) using Wilcoxon rank sum test of cigarettes per day and snus pouches per day, and a linear mixed model (biomarkers).

resultsCompared to the PS and UB groups, smokers assigned to CS reported greater reductions in cigarettes per day (ps < .001), using more snus pouches per day (p = .02), and more smoke-free days (CS median = 14.5, PS and UB medians = 0, p < .001). In addition, results demonstrated reductions in carbon monoxide (p < .001), total nicotine equivalents (p = .02), and four out of five measured volatile organic compounds (ps < .01) over time among the CS group. Exposure to N'-nitrosonornicotine increased by trial end only among the PS group (p < .04). Phenanthrene tetraol increased among all groups by trial end (p = .02) with no difference between groups.

conclusionsInstructions to completely switch from cigarettes to snus resulted in the greatest reduction in cigarettes and exposure to harmful constituents. IMPLICATIONS: Directly instructing smokers to switch completely to snus, rather than using ad libitum (with no instructions to avoid cigarettes), is necessary for reductions in smoking and subsequent exposure to harmful constituents.

Indexed as

AdolescentAdultBiomarkersCarbon MonoxideFemaleHumansMaleMiddle AgedMinnesotaNew YorkNitrosaminesSmokingSmoking CessationTobacco, SmokelessTobacco Use DisorderYoung AdultBiomarkersCarbon MonoxideNitrosaminesN'-nitrosonornicotine

Identifiers

PMID31321423
PMCPMC7164575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.